Sundaram Multi Pap (SUNDARAM)₹1.04−1.89%Stationary
In the Mar 2026 quarter (standalone), Sundaram Multi Pap reported sales of ₹44.32 Cr, up 11.9% from Mar 2025, and net profit of ₹1.16 Cr. For the year to Mar 2026, sales were ₹137 Cr and net profit ₹2.99 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 42.25 | 22.26 | 21.90 | 40.47 | 42.33 | 23.98 | 21.34 | 39.62 | 40.58 | 25.98 | 26.04 | 44.32 |
| Expenses | 40.14 | 22.58 | 22.45 | 37.98 | 38.75 | 24.06 | 22.29 | 40.85 | 39.55 | 24.33 | 24.02 | 43.54 |
| Operating Profit | 2.24 | −0.23 | −0.46 | 2.59 | 3.74 | −0.03 | −0.89 | −1.15 | 1.15 | 1.74 | 2.11 | 0.89 |
| OPM % | 5.3% | −1.1% | −2.1% | 6.4% | 8.8% | −0.2% | −4.2% | −2.9% | 2.8% | 6.8% | 8.1% | 2.0% |
| Other Income | −1.17 | −0.33 | 0.39 | −0.49 | −1.80 | −0.11 | 0.11 | 2.07 | 0.17 | 0.05 | 1.04 | 1.28 |
| Interest | 0.92 | 0.76 | 0.97 | 0.77 | 0.61 | 0.60 | 0.78 | 0.65 | 0.69 | −0.07 | 0.45 | 0.46 |
| Depreciation | 0.96 | 1.01 | 1.06 | 1.09 | 1.05 | 1.10 | 1.09 | 1.08 | 1.03 | 1.03 | 1.04 | 0.50 |
| Profit before tax | −0.82 | −2.34 | −2.13 | 0.23 | 0.25 | −1.83 | −2.68 | −0.84 | −0.43 | 0.82 | 1.61 | 1.16 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Exceptional items | −0.99 | 0.00 | 0.00 | −0.99 | −1.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | −0.82 | −2.34 | −2.13 | 0.23 | 0.24 | −1.82 | −2.68 | −0.84 | −0.43 | 0.82 | 1.61 | 1.16 |
| EPS (Rs) | −0.01 | −0.04 | −0.04 | 0.00 | 0.00 | −0.03 | −0.05 | −0.01 | 0.00 | 0.01 | 0.02 | 0.01 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 95.87 | 93.82 | 106 | 99.81 | 96.86 | 50.95 | 69.89 | 114 | 127 | 127 | 137 | 137 |
| Expenses | 84.11 | 79.06 | 95.18 | 85.05 | 90.14 | 52.08 | 59.10 | 105 | 123 | 126 | 131 | 131 |
| Operating Profit | 11.99 | 14.99 | 11.99 | 15.01 | 6.99 | −1.01 | 10.99 | 10.01 | 4.01 | 1.99 | 6.01 | 5.89 |
| OPM % | 12.0% | 16.0% | 11.1% | 15.1% | 7.0% | −2.7% | 16.0% | 8.1% | 3.4% | 1.3% | 4.3% | 4.3% |
| Other Income | −4.01 | −8.03 | −16.06 | 2.01 | 5.02 | 2.01 | 2.01 | 1.01 | −2.01 | 0.00 | 3.01 | 2.54 |
| Interest | 11.96 | 9.97 | 8.97 | 6.98 | 9.97 | 5.99 | 4.98 | 3.99 | 3.99 | 2.99 | 1.99 | 1.53 |
| Depreciation | 2.99 | 1.99 | 1.99 | 4.01 | 3.99 | 3.99 | 3.99 | 3.99 | 4.01 | 3.99 | 3.99 | 3.60 |
| Profit before tax | −7.99 | −4.99 | −14.98 | 5.99 | −2.99 | −8.99 | 3.99 | 2.99 | −4.99 | −4.99 | 2.99 | 3.16 |
| Tax % | −18.0% | 0.0% | 0.0% | 0.0% | 0.0% | −2.0% | 3.0% | 2.0% | 0.0% | 0.0% | 0.0% | — |
| Exceptional items | −6.99 | −9.99 | −17.99 | 0.00 | 1.99 | 0.00 | −0.99 | −2.99 | −1.99 | 0.00 | 0.00 | 0.00 |
| Net Profit | −5.98 | −4.98 | −14.95 | 5.98 | −2.99 | −8.97 | 3.99 | 2.99 | −4.99 | −4.99 | 2.99 | 3.16 |
| EPS (Rs) | −0.29 | −0.19 | −0.54 | 0.21 | −0.09 | −0.18 | 0.07 | 0.04 | −0.10 | −0.10 | 0.06 | 0.04 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 21.94 | 21.98 | 24.96 | 26.98 | 46.93 | 46.87 | 46.88 | 46.92 | 46.89 | 46.92 | 46.90 | 46.88 |
| Reserves | 90.88 | 79.95 | 78.94 | 68.99 | 54.91 | 51.95 | 43.93 | 47.92 | 49.91 | 44.95 | 39.94 | 42.89 |
| Borrowings | 103 | 90.89 | 64.00 | 55.93 | 42.92 | 44.93 | 43.91 | 38.92 | 34.94 | 31.94 | 26.96 | 20.94 |
| Other Liabilities | 16.92 | 13.97 | 29.85 | 22.89 | 16.92 | 12.95 | 12.94 | 11.94 | 5.97 | 9.95 | 6.97 | 3.98 |
| Total Liabilities | 232 | 207 | 196 | 175 | 163 | 158 | 148 | 146 | 138 | 135 | 122 | 116 |
| Fixed Assets | 95.96 | 86.93 | 53.94 | 52.96 | 66.98 | 63.92 | 59.93 | 56.96 | 70.91 | 68.94 | 50.99 | 51.92 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 15.04 | 25.07 | 39.07 | 39.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 121 | 93.79 | 104 | 83.76 | 95.70 | 93.78 | 87.73 | 88.74 | 66.80 | 64.82 | 70.78 | 63.77 |
| Inventories | 63.78 | 41.77 | 24.52 | 36.62 | 39.16 | 38.87 | 30.79 | 33.30 | 33.87 | 40.95 | 32.71 | 40.50 |
| Trade receivables | 21.77 | 27.09 | 24.89 | 16.24 | 21.25 | 17.08 | 17.53 | 15.87 | 12.62 | 11.90 | 14.72 | 13.50 |
| Cash & equivalents | 0.62 | 1.33 | 0.17 | 0.04 | 0.39 | 0.89 | 0.38 | 0.37 | 2.55 | 0.23 | 14.24 | 0.21 |
| Total Assets | 232 | 207 | 196 | 175 | 163 | 158 | 148 | 146 | 138 | 135 | 122 | 116 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 28.90 | 20.93 | 0.99 | 3.98 | 7.97 | 2.99 | 5.98 | 4.98 | 10.95 | 4.98 | 6.98 | −1.99 |
| Cash from investing activity | 14.96 | 9.98 | 0.99 | 4.99 | −3.99 | 3.99 | 1.99 | 0.00 | −0.99 | −1.99 | 15.95 | −4.99 |
| Cash from financing activity | −44.15 | −31.08 | −3.01 | −9.03 | −3.01 | −7.02 | −8.02 | −5.02 | −9.04 | −6.02 | −9.03 | −7.02 |
| Net cash flow | 0.00 | 0.99 | −0.99 | 0.00 | 0.00 | 0.00 | −0.99 | 0.00 | 1.99 | −1.99 | 13.97 | −13.98 |
| Capex | 0.57 | 0.02 | 0.22 | 0.36 | 6.28 | 0.69 | 0.35 | 0.45 | 0.51 | 1.91 | 0.00 | 4.72 |
| Free cash flow | 41.01 | 29.99 | 0.99 | 4.01 | 2.01 | 6.01 | 5.01 | 5.01 | 11.01 | 3.01 | 23.01 | −6.99 |
| CFO / OP % | 2,490.0% | 174.0% | 8.0% | 35.0% | 54.0% | 46.0% | −414.0% | 49.0% | 119.0% | 126.0% | 418.0% | −37.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 95 | 103 | 96 | 56 | 78 | 64 | 126 | 82 | 40 | 34 | 42 | 36 |
| Inventory days | 339 | 206 | 130 | 172 | 212 | 200 | 300 | 282 | 154 | 150 | 127 | 157 |
| Days payable | 49 | 46 | 64 | 82 | 44 | 12 | 50 | 27 | 10 | 23 | 10 | 0 |
| Cash conversion cycle | 384 | 262 | 161 | 145 | 245 | 251 | 375 | 336 | 184 | 160 | 158 | 191 |
| Working capital days | 225 | 45 | 60 | 51 | 156 | 216 | 369 | 276 | 156 | 134 | 78 | 110 |
| ROCE % | 1.0% | 6.0% | 8.0% | 8.0% | 9.0% | 3.0% | −2.0% | 8.0% | 7.0% | 0.0% | −2.0% | 4.0% |
For the Mar 2026 quarter, Sundaram Multi Pap reported sales of ₹44.32 Cr, up 11.9% year on year and net profit of ₹1.16 Cr. The operating margin was 2.0%.
Sundaram Multi Pap's sales for the year to Mar 2026 were ₹137 Cr; over the last twelve months they were ₹137 Cr.
Net profit for the year to Mar 2026 was ₹2.99 Cr, and ₹3.16 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.04.
Sundaram Multi Pap reported borrowings of ₹20.94 Cr at Mar 2026, against cash and equivalents of ₹0.21 Cr.
Cash from operations was −₹1.99 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹6.99 Cr.